☆ 4.7 Article

Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics

PHARMACOLOGICAL RESEARCH (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

In-silico study of the interactions between acylated glucagon like-peptide-1 analogues and the native receptor

Tine Maja Frimann et al.

Summary: In this study, we used molecular dynamics simulations to investigate the binding of glucagon-like peptide-1 (GLP-1) and acylated GLP-1 analogues with the endogenous receptor (GLP-1R). The results showed that the fatty acid (FA) chain structure, acylation position on the peptide, and presence of a linker all played important roles in the binding. Analysis of the simulations revealed that the major differences between the systems were due to the FA interactions and positioning of acylation on the peptide. Hydrophobic interactions between the FA chain and a hydrophobic patch on the extracellular domain significantly contributed to the binding affinity. Furthermore, the presence of a charged linker between the peptide and FA chain could stabilize the complex by forming hydrogen bonds. These findings provide important insights into designing acylated agonists for GLP-1R.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide

Jiangchuan Long et al.

Summary: This study found an association between GLP-1R SNPs and GIARs in patients with type 2 diabetes treated with liraglutide. Female sex, the T allele at rs2254336, and the A allele at rs3765467 may serve as predictors of GIARs caused by liraglutide.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The therapeutic potential of GLP-1 receptor biased agonism

Ben Jones

Summary: GLP-1 receptor agonists are effective treatments for type 2 diabetes by stimulating insulin release and promoting weight loss, but their main side effect is nausea. Recent studies suggest that biased GLP-1 agonists may achieve enhanced anti-hyperglycaemic efficacy by avoiding receptor desensitization and downregulation, particularly through reduced beta-arrestin recruitment, although more human data is needed for confirmation.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Structural determinants of dual incretin receptor agonism by tirzepatide

Bingfa Sun et al.

Summary: Tirzepatide is a dual incretin receptor agonist that improves glucose control and body weight regulation in type 2 diabetes mellitus. Mechanistic pharmacology studies combined with cryogenic electron microscopy have provided insights into the structural basis and interactions of Tirzepatide with GIPR and GLP-1R.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Association of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed meal

Mona Mashayekhi et al.

Summary: Genetic variation in the gene encoding the GLP-1 receptor may affect the metabolic response to DPP-4 inhibitors. The rs6923761 variant was associated with decreased postprandial glucose excursion in individuals with type 2 diabetes and hypertension. The study suggests a potential role of GLP1R rs6923761 genotype in modulating GLP-1 signaling in response to treatment.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor

Rachel M. Johnson et al.

Summary: Dual agonists that can activate both GLP-1R and GIPR have high efficacy in treating metabolic disease, with peptide-19 being a potent prototype. The complex of peptide-19:GLP-1R:Gs exhibits a more open binding pocket and high dynamicity in the TM binding pocket. This structure provides unique insights into GLP-1R activation by this dual agonist.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

Melissa K. Thomas et al.

Summary: Tirzepatide demonstrated significantly greater improvements in insulin sensitivity and beta-cell function compared to dulaglutide, with only partial contributions from weight loss. The dual receptor agonism of tirzepatide may confer distinct mechanisms of glycemic control beyond just weight reduction.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Review Nutrition & Dietetics

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective

Joanna Michalowska et al.

Summary: The global prevalence of obesity continues to increase rapidly, leading to serious diet-related noncommunicable diseases. Understanding the pathogenesis of obesity is crucial for developing effective treatment strategies, with incretin mimetics providing new therapeutic options in this field.

NUTRIENTS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

AlphaFold and the amyloid landscape

Francisca Pinheiro et al.

Summary: Protein aggregation is a widespread phenomenon with functional amyloids playing important roles in physiology, while structural details of most amyloidogenic species remain elusive.

JOURNAL OF MOLECULAR BIOLOGY (2021)

添加到收藏夹

Article Biology

GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo

Alba C. Arcones et al.

Summary: This study demonstrates that GRK2 plays an important negative regulatory role in GLP-1R-mediated insulin secretion, with potential therapeutic implications for enhancing beta-cell insulin secretion specifically during the early phase. The results suggest that GRK2 is involved in regulating the size and release efficacy of insulin granules and that it is required for beta-arrestin recruitment downstream of GLP-1R stimulation.

BMC BIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial

Melanie Davies et al.

Summary: In this study, once-weekly subcutaneous semaglutide 2.4 mg was shown to achieve a significantly greater and clinically meaningful weight reduction compared to placebo in adults with overweight or obesity and type 2 diabetes. Adverse events, particularly gastrointestinal events, were more common with semaglutide compared to placebo.

LANCET (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist

Phil Pickford et al.

Summary: By reducing 13-arrestin-2 recruitment, this study found that the duration of glucose-lowering action can be prolonged, increasing the therapeutic efficacy of GLP-1R/GCGR co-agonists. Retaining potential benefits of GCGR agonism, the tested compounds showed only partial agonism in both pathways.

MOLECULAR METABOLISM (2021)

添加到收藏夹

Meeting Abstract Endocrinology & Metabolism

The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes

Tamer Coskun et al.

DIABETES (2021)

添加到收藏夹

Article Endocrinology & Metabolism

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models

Tito Borner et al.

Summary: GIPR signaling blocks emesis and attenuates illness behaviors induced by GLP-1R activation while maintaining reduced food intake, weight loss, and improved glucose tolerance. The hindbrain AP/NTS is crucial for processing GLP-1R ligand-induced effects on food intake and weight suppression, as well as emetic stimuli.

DIABETES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Highly accurate protein structure prediction with AlphaFold

John Jumper et al.

Summary: Proteins are essential for life, and accurate prediction of their structures is a crucial research problem. Current experimental methods are time-consuming, highlighting the need for accurate computational approaches to address the gap in structural coverage. Despite recent progress, existing methods fall short of atomic accuracy in protein structure prediction.

NATURE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Aditi R. Saxena et al.

Summary: In this study, danuglipron showed good tolerability in T2D patients, with a safety profile consistent with the mechanism of action of GLP-1R agonism.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

High-accuracy protein structure prediction in CASP14

Joana Pereira et al.

Summary: The application of state-of-the-art deep-learning approaches to protein modeling problem has expanded the high-accuracy category in CASP14, evaluating the performance of different groups and introducing new metrics. Despite the significant progress made by AlphaFold2, the second-best method in CASP14 outperformed the best method in CASP13, demonstrating the role of community-based benchmarking in the development of protein structure prediction field.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor

Zhaotong Cong et al.

Summary: This study reports the cryo-EM structures of GLP-1R bound to an ago-allosteric modulator, revealing how the modulator executes positive allosteric modulation by enhancing both agonist binding and G protein coupling.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Cell Biology

Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes

Xin Zhang et al.

Summary: GLP-1R agonists play a crucial role in the treatment of diabetes and obesity, but a lack of structural information limits the understanding of their molecular mechanisms. Studies have shown that semaglutide and taspoglutide have similar peptide interactions with GLP-1R, but exhibit different motions between the receptor and bound peptides.

CELL REPORTS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening

Qingtong Zhou et al.

Summary: Allosteric modulators offer pharmacological advantages by affecting downstream signaling without competing for orthosteric sites. Computational approaches were used to identify allosteric modulators targeting GLP-1R, resulting in the discovery of negative and positive modulators through structure-based and ligand-based virtual screening methods, respectively. This computational approach may be applicable for discovering allosteric modulators of other GPCRs.

BIOMOLECULES (2021)

添加到收藏夹

Article Chemistry, Medicinal

GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats

Wijnand J. C. van der Velden et al.

Summary: Biased ligands are pharmacologically important for reducing on-target side effects and improving drug efficacy. This study investigated the effects of a N-terminal modification in GLP-1 on GLP-1 receptor signaling, revealing significant impairments in internalization and alterations in molecular pharmacological properties. The findings suggest that subtle changes in the N-terminus of GLP-1 can induce profound differences in therapeutic targeting of the GLP-1 system, which may facilitate the development of optimized GLP-1R agonists.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system

Maria Buur Nordskov Gabe et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors

Anna Urgeova et al.

PHARMACOGENOMICS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors

Elita Yuliantie et al.

BIOCHEMICAL PHARMACOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard et al.

JCI INSIGHT (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists

Xin Zhang et al.

MOLECULAR CELL (2020)

添加到收藏夹

Review Endocrinology & Metabolism

GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art

Michael A. Nauck et al.

MOLECULAR METABOLISM (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes

Okechi S. Oduori et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Chemistry, Medicinal

Cryo-EM as a powerful tool for drug discovery

John H. Van Drie et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Takahiro Kawai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells

Zijian Fang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes

Juan P. Frias

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2020)

添加到收藏夹

Article Biochemical Research Methods

AlphaFold at CASP13

Mohammed AlQuraishi

BIOINFORMATICS (2019)

添加到收藏夹

Review Endocrinology & Metabolism

The Discovery and Development of Liraglutide and Semaglutide

Lotte Bjerre Knudsen et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor

Noura Al-Zamel et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Review Medicine, General & Internal

GLP-1 Receptor Agonists and Kidney Protection

Eulalia Valentina Greco et al.

MEDICINA-LITHUANIA (2019)

添加到收藏夹

Article Cell Biology

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake

Alice E. Adriaenssens et al.

CELL METABOLISM (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

GLP-1: Molecular mechanisms and outcomes of a complex signaling system

Nicholas K. Smith et al.

NEUROCHEMISTRY INTERNATIONAL (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells

Teresa Buenaventura et al.

PLOS BIOLOGY (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Glucagon-like peptide 1 (GLP-1)

T. D. Mueller et al.

MOLECULAR METABOLISM (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of an endosomal signaling GPCR-G protein-β-arrestin megacomplex

Anthony H. Nguyen et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

添加到收藏夹

Meeting Abstract Endocrinology & Metabolism

Novel Combination of a Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) and Once-Weekly Basal Insulin (HM12460a) Offers Improved Glucose Lowering and Weight Loss in a Diabetic Animal Model

Jung Kuk Kim et al.

DIABETES (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes

Megan E. Capozzi et al.

ENDOCRINE REVIEWS (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism

Saifei Lei et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting GLP-1 receptor trafficking to improve agonist efficacy

Ben Jones et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists

Madeleine M. Fletcher et al.

BIOCHEMICAL PHARMACOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex

Yi-Lynn Liang et al.

NATURE (2018)

添加到收藏夹

Article Endocrinology & Metabolism

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

Tamer Coskun et al.

MOLECULAR METABOLISM (2018)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms

Pierre-Yves Jean-Charles et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Yan Zhang et al.

NATURE (2017)

添加到收藏夹

Article Endocrinology & Metabolism

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott et al.

DIABETES (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

The complexity of signalling mediated by the glucagon-like peptide-1 receptor

Madeleine M. Fletcher et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling

Alex R. B. Thomsen et al.

CELL (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism

Denise Wootten et al.

CELL (2016)

添加到收藏夹

Article Endocrinology & Metabolism

A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins

M. Javorsky et al.

DIABETES OBESITY & METABOLISM (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors

Li-Hua Zhao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues

Marlies V. Hager et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

添加到收藏夹

Article Cell Biology

An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain

Yanting Yin et al.

CELL DISCOVERY (2016)

添加到收藏夹

Article Pharmacology & Pharmacy

Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the G alpha(q) pathway

Aiysha Thompson et al.

BIOCHEMICAL PHARMACOLOGY (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Feng Sun et al.

CLINICAL THERAPEUTICS (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor

Daniel Antonio de Luis et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects

Hongkai Zhang et al.

NATURE COMMUNICATIONS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility

Jennifer Wessel et al.

NATURE COMMUNICATIONS (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking

Sarah Noerklit Roed et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model

Paul Richards et al.

DIABETES (2014)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Tissue-Specific Expression of GLP1R in Mice: Is the Problem of Antibody Nonspecificity Solved?

Annayya Aroor et al.

DIABETES (2014)

添加到收藏夹

Article Endocrinology & Metabolism

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

Charles Pyke et al.

ENDOCRINOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Visualization of arrestin recruitment by a G-protein-coupled receptor

Arun K. Shukla et al.

NATURE (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic β-cells

Ramya S. Kuna et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor

Susmith Mukund et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

添加到收藏夹

Review Pharmacology & Pharmacy

The structure and function of the glucagon-like peptide-1 receptor and its ligands

Dan Donnelly

BRITISH JOURNAL OF PHARMACOLOGY (2012)

添加到收藏夹

Article Cell Biology

β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells

Jason Talbot et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular basis for negative regulation of the glucagon receptor

Christopher M. Koth et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

添加到收藏夹

Article Pharmacology & Pharmacy

Polymorphism and Ligand Dependent Changes in Human Glucagon-Like Peptide-1 Receptor (GLP-1R) Function: Allosteric Rescue of Loss of Function Mutation

Cassandra Koole et al.

MOLECULAR PHARMACOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Retromer terminates the generation of cAMP by internalized PTH receptors

Timothy N. Feinstein et al.

NATURE CHEMICAL BIOLOGY (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Phospholipase C-ε links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans

Igor Dzhura et al.

ISLETS (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects A pilot study

Airani Sathananthan et al.

DIABETES CARE (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening

Cassandra Koole et al.

MOLECULAR PHARMACOLOGY (2010)

添加到收藏夹

Review Endocrinology & Metabolism

GIP and GLP-1, the two incretin hormones: Similarities and differences

Yutaka Seino et al.

JOURNAL OF DIABETES INVESTIGATION (2010)

添加到收藏夹

Article Multidisciplinary Sciences

β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells

Noriyuki Sonoda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Peptide binding at the GLP-1 receptor

R. Mann et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2007)

添加到收藏夹

Article Multidisciplinary Sciences

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice

Desu Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

添加到收藏夹

Article Endocrinology & Metabolism

Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor

Colin A. Syme et al.

MOLECULAR ENDOCRINOLOGY (2006)

添加到收藏夹

Article Biotechnology & Applied Microbiology

AceView: a comprehensive cDNA-supported gene and transcripts annotation

Danielle Thierry-Mieg et al.

GENOME BIOLOGY (2006)

添加到收藏夹

Article Endocrinology & Metabolism

A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness

M Beinborn et al.

REGULATORY PEPTIDES (2005)

添加到收藏夹

Article Endocrinology & Metabolism

The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation

P Vázquez et al.

JOURNAL OF ENDOCRINOLOGY (2005)

添加到收藏夹

Review Endocrinology & Metabolism

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

JJ Holst et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)

添加到收藏夹

Article Endocrinology & Metabolism

The incretin approach for diabetes treatment - Modulation of islet hormone release by GLP-1 agonism

JJ Holst et al.

DIABETES (2004)

添加到收藏夹

Article Endocrinology & Metabolism

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell

GG Holz

DIABETES (2004)

添加到收藏夹

Article Endocrinology & Metabolism

Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population

Y Tokuyama et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antagonism of rat β-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways

PE MacDonald et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Epac-selective cAMP analog 8-pCPT-2′-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic β-cells

GX Kang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Recruitment of activated G protein-coupled receptors to pre-existing clathrin-coated pits in living cells

MGH Scott et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.